|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.090 CNY | -0.14% |
|
-1.25% | -2.21% |
| Jan. 06 | Sichuan Kelun-Biotech Subscribes to Wealth Management Products | MT |
| Jan. 06 | Sichuan Kelun-Biotech Biopharmaceutical subscribes for wealth management products | RE |
| Capitalization | 584B 83.76B 71.97B 67.11B 62.36B 116B 7,564B 125B 772B 303B 3,615B 314B 308B 13,332B | P/E ratio 2025 * |
5.51x | P/E ratio 2026 * | 5.6x |
|---|---|---|---|---|---|
| Enterprise value | 584B 83.76B 71.97B 67.11B 62.36B 116B 7,564B 125B 772B 303B 3,615B 314B 308B 13,332B | EV / Sales 2025 * |
2.25x | EV / Sales 2026 * | 2.17x |
| Free-Float |
40.24% | Yield 2025 * |
5.64% | Yield 2026 * | 5.62% |
More valuation ratios
* Estimated data
More news
More press releases
More news
| 1 day | -0.14% | ||
| 1 week | -1.25% | ||
| Current month | -2.21% | ||
| 1 month | -3.54% | ||
| 3 months | +5.51% | ||
| 6 months | -11.93% | ||
| Current year | -2.21% |
| 1 week | 7.02 |  | 7.16 |
| 1 month | 7.02 | | 7.48 |
| Current year | 7.02 | | 7.28 |
| 1 year | 6.65 | | 8.34 |
| 3 years | 4.81 | | 8.34 |
| 5 years | 4.25 | | 8.34 |
| 10 years | 4.25 | | 8.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bin Qian
CTO | Chief Tech/Sci/R&D Officer | 54 | 2021-06-30 |
Jiuyong Yin
PRN | Corporate Officer/Principal | 59 | 2019-08-31 |
Wan Fu Zhou
PRN | Corporate Officer/Principal | 60 | 2020-03-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Xiang Dong Zhang
BRD | Director/Board Member | 69 | 2020-08-20 |
Jun Ma
BRD | Director/Board Member | 63 | 2022-06-27 |
Xiao Hui Li
BRD | Director/Board Member | 59 | 2020-11-17 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.14% | -1.25% | - | - | 83.69B | |
| -4.19% | -7.09% | +27.31% | +117.40% | 883B | |
| -1.18% | -4.73% | +21.04% | +54.81% | 403B | |
| -0.63% | +2.12% | +28.48% | +47.53% | 369B | |
| -1.47% | -2.94% | +32.65% | +111.58% | 298B | |
| +0.86% | -0.38% | +51.92% | +105.14% | 278B | |
| -0.13% | +2.23% | +30.49% | +53.05% | 266B | |
| -0.32% | -0.38% | +37.32% | +74.68% | 238B | |
| -0.22% | +0.67% | +18.52% | +50.34% | 237B | |
| +1.78% | +7.87% | +51.92% | +197.68% | 189B | |
| Average | -0.29% | -1.08% | +33.30% | +90.24% | 351.15B | |
| Weighted average by Cap. | -1.02% | -2.55% | +31.15% | +90.80% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 260B 37.24B 32B 29.84B 27.73B 51.74B 3,364B 55.79B 343B 135B 1,607B 140B 137B 5,928B | 270B 38.65B 33.21B 30.97B 28.78B 53.7B 3,491B 57.91B 356B 140B 1,668B 145B 142B 6,152B |
| Net income | 95.46B 13.68B 11.76B 10.97B 10.19B 19.01B 1,236B 20.5B 126B 49.53B 591B 51.32B 50.27B 2,178B | 97.83B 14.02B 12.05B 11.24B 10.44B 19.48B 1,267B 21.01B 129B 50.76B 605B 52.59B 51.51B 2,232B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
95,746
Sector
Banks
Calendar
Mar. 27
- Q4 2025 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-13 | 7.090 ¥ | -0.14% | 134,331,900 |
| 26-01-12 | 7.100 ¥ | +0.42% | 145,403,900 |
| 26-01-09 | 7.070 ¥ | -0.28% | 96,956,410 |
| 26-01-08 | 7.090 ¥ | -0.56% | 115,416,700 |
| 26-01-07 | 7.130 ¥ | -0.70% | 117,423,700 |
End-of-day quote Shanghai S.E., January 12, 2026
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
5.884CNY
Average target price
6.798CNY
Spread / Average Target
+15.53%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 3328 Stock
- 601328 Stock
Select your edition
All financial news and data tailored to specific country editions
